Prime Editing Promises Greater Precision, Safety.
Cancer discovery, 10(1): OF1 PMID 31740585 DOI 10.1158/2159-8290.CD-ND2019-014
Abstract
Cancer researchers are heralding the arrival of prime editing, an ultra-precise twist on CRISPR genome engineering, as a powerful new tool for disease modeling, target validation, and clinical applications.